JP2009544675A5 - - Google Patents

Download PDF

Info

Publication number
JP2009544675A5
JP2009544675A5 JP2009521318A JP2009521318A JP2009544675A5 JP 2009544675 A5 JP2009544675 A5 JP 2009544675A5 JP 2009521318 A JP2009521318 A JP 2009521318A JP 2009521318 A JP2009521318 A JP 2009521318A JP 2009544675 A5 JP2009544675 A5 JP 2009544675A5
Authority
JP
Japan
Prior art keywords
methyl
butyl
oxy
carboxy
biphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009521318A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009544675A (ja
Filing date
Publication date
Priority claimed from FR0606752A external-priority patent/FR2903984B1/fr
Application filed filed Critical
Publication of JP2009544675A publication Critical patent/JP2009544675A/ja
Publication of JP2009544675A5 publication Critical patent/JP2009544675A5/ja
Pending legal-status Critical Current

Links

JP2009521318A 2006-07-24 2007-07-24 置換されたイミダゾロン誘導体、製造方法及び使用 Pending JP2009544675A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0606752A FR2903984B1 (fr) 2006-07-24 2006-07-24 Derives d'imidazolones substitues, preparation et utilisations
PCT/FR2007/051716 WO2008012470A2 (fr) 2006-07-24 2007-07-24 Derives d'imidazolones substitues, preparation et utilisations

Publications (2)

Publication Number Publication Date
JP2009544675A JP2009544675A (ja) 2009-12-17
JP2009544675A5 true JP2009544675A5 (enExample) 2010-07-22

Family

ID=37843186

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009521318A Pending JP2009544675A (ja) 2006-07-24 2007-07-24 置換されたイミダゾロン誘導体、製造方法及び使用

Country Status (16)

Country Link
US (1) US20100004159A1 (enExample)
EP (1) EP2049107A2 (enExample)
JP (1) JP2009544675A (enExample)
KR (1) KR20090038469A (enExample)
CN (1) CN101522192A (enExample)
AU (1) AU2007279135A1 (enExample)
BR (1) BRPI0715326A2 (enExample)
CA (1) CA2658625A1 (enExample)
EA (1) EA200900211A1 (enExample)
FR (1) FR2903984B1 (enExample)
IL (1) IL196671A0 (enExample)
MX (1) MX2009000900A (enExample)
NO (1) NO20090348L (enExample)
NZ (1) NZ575011A (enExample)
WO (1) WO2008012470A2 (enExample)
ZA (1) ZA200901268B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
JP2013523642A (ja) * 2010-03-26 2013-06-17 メルク・シャープ・エンド・ドーム・コーポレイション グルカゴン受容体拮抗薬としての新規なスピロイミダゾロン誘導体、組成物およびそれらの使用方法
EP2582709B1 (de) 2010-06-18 2018-01-24 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
US8633231B2 (en) 2010-07-13 2014-01-21 Merck Sharp & Dohme Corp. Substituted imidazolones, compositions containing such compounds and methods of use
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2760862B1 (en) 2011-09-27 2015-10-21 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
PT3013796T (pt) * 2013-06-27 2020-03-26 Lg Chemical Ltd Derivados biarílicos como agonistas de gpr120
CA2934257C (en) 2013-12-17 2022-06-07 Janssen Pharmaceutica Nv Imidazolin-5-one derivative useful as fasn inhibitors for the treatment of cancer
CN105439946B (zh) * 2014-08-13 2018-02-02 益方生物科技(上海)有限公司 羧酸化合物及其制备方法和用途
CN104177298B (zh) * 2014-09-18 2018-10-02 湘潭大学 4,4-二取代-4,5-二氢-1h–咪唑-5-酮、衍生物及其合成方法
EP3799873A1 (en) 2015-07-17 2021-04-07 Institut Pasteur 5-hydroxytryptamine 1b receptor-stimulating agent for use as a promoter of satellite cells self-renewal and/or differentiation
TW201713631A (zh) * 2015-09-11 2017-04-16 拉夸里亞創藥股份有限公司 作為trpm8拮抗劑之咪唑啉酮衍生物
WO2017172368A1 (en) 2016-03-31 2017-10-05 Oncternal Therapeutics, Inc. Indoline analogs and uses thereof
BR112019000706A8 (pt) 2016-07-15 2022-12-06 Pasteur Institut Agente de estímulo do receptor 1b de 5-hidroxitriptamina para reparo de pele e/ou cabelo
CN113121394B (zh) * 2019-12-30 2022-11-08 中国药科大学 一种苯氧乙酸类衍生物的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0402486A3 (en) * 2001-11-30 2007-05-02 Lilly Co Eli Nitrogen containing heterocyclic compounds as peroxisome proliferator activated receptor agonists, their use and pharmaceutical compositions cointaining them
US7232828B2 (en) * 2002-08-10 2007-06-19 Bethesda Pharmaceuticals, Inc. PPAR Ligands that do not cause fluid retention, edema or congestive heart failure
US20050020654A1 (en) * 2003-03-15 2005-01-27 Pershadsingh Harrihar A. Novel PPAR agonists, pharmaceutical compositions and uses thereof

Similar Documents

Publication Publication Date Title
AU2002349754B2 (en) Novel 1,2,4-triazole compound
RU2407740C2 (ru) Гетеробициклические сульфонамидные производные для лечения диабета
JP2005521642A5 (enExample)
JP2007530698A5 (enExample)
JP2009540009A5 (enExample)
JP2007502265A5 (enExample)
JP2010506825A5 (enExample)
RU2008125196A (ru) Новые производные тиофена
JP2007519659A5 (enExample)
JP2005524660A5 (enExample)
NZ594122A (en) 2-Phenyl-N-(2-(6-(pyrrolidin-1-ylmethyl)thiazolo[5,4-b]pyridin-2-yl)phenyl)thiazole-4-carboxamide derivatives
JP2007520471A5 (enExample)
JP2006508935A5 (enExample)
JP2010077137A5 (enExample)
JP2010504286A5 (enExample)
JP2007508359A5 (enExample)
JP2009535307A5 (enExample)
JP2006077019A5 (enExample)
CA2513092A1 (en) Compounds for the treatment of metabolic disorders
JP2009531376A5 (enExample)
JP2009543795A5 (enExample)
RU2013127155A (ru) Новые замещенные бициклические ароматические соединения в качестве ингибиторов s-нитрозоглутатион-редуктазы
JP2007505091A5 (enExample)
JP2008540574A5 (enExample)
RU2005117789A (ru) Производные 4,5-диарилтиазола в качестве лигандов св-1